A total of 1243 differentially expressed genes (DEGs) were identified in CD34+ cells between myeloma patients (n = 8) and healthy donors (n = 3), 852 of which were upregulated and 391 of which were downregulated (FC > 2.0, p < 0.01; Fig. 5A). This evidence concerns the gene CD34 and plasma cell myeloma.